文献速递肝病消化道肿瘤与早癌

Fontan相关肝病肝细胞癌的基因组与转录组特征

Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease.
PubMed 文献 · Hepatology · 2026-01-26

FALD HCC肿瘤突变负荷与其他HCC相当,突变特征与DNA双链断裂修复缺陷相关;拷贝数改变和结构变异较多,转录组归为祖细胞表型,属预后不良亚类。

要点

  • FALD HCC突变特征与DNA双链断裂修复缺陷相关。
  • FALD HCC拷贝数改变和结构变异较多,可能触发癌变。
  • FALD HCC转录组归为祖细胞表型,属预后不良亚类。

核心结论

  • FALD和非Fontan CHS HCC的基因组突变谱不同于其他病因HCC。
  • FALD HCC的拷贝数改变和转录谱将其归为预后不良HCC组。

研究设计与样本

  • 行全基因组测序和转录组测序,与公共数据库其他病因HCC比较。

主要发现

  • FALD HCC肿瘤突变负荷与数据库HCC相当。
  • FALD HCC突变特征与DNA双链断裂修复缺陷相关。
  • FALD和非Fontan CHS HCC拷贝数改变和结构变异较多,包括短缺失和易位。
  • FALD FNH中罕见上述结构变异。
  • FALD和非Fontan CHS HCC转录组归为祖细胞表型。

关键数值与推荐

  • FALD HCC肿瘤突变负荷与数据库其他HCC相当。
  • FALD和非Fontan CHS HCC拷贝数改变和结构变异较多,FALD FNH中罕见。
  • FALD HCC转录组归为祖细胞表型,属预后不良组。

临床怎么用

  • FALD HCC基因组特征提示DNA双链断裂修复缺陷和结构变异在癌变中可能起作用。
  • FALD HCC转录组祖细胞表型提示预后不良,或可辅助风险分层。

局限性

  • 结果需更大样本验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Fontan-associated liver disease (FALD) could lead to liver cirrhosis and hepatocellular carcinoma (HCC). The prognosis of FALD patients is worse when HCC develops. Therefore, a better understanding of the mechanisms of FALD hepatocarcinogenesis is critical. We investigated the genomic and transcriptomic signatures of FALD HCC. APPROACH AND RESULTS: Ten patients with FALD HCCs, 2 patients with non-Fontan congenital heart surgery (CHS) HCC, and 1 patient with FALD focal nodular hyperplasia (FNH) were enrolled. Whole-genome sequencing and transcriptome sequencing were performed, and the results were compared with other etiology-related HCCs in common databases. FALD HCCs exhibited comparable tumor mutation burdens to those of HCCs in the databases, as well as mutation signatures related to DNA double-strand break repair deficiency. These features were shared by non-Fontan CHS HCCs and FALD FNH, suggesting that postoperative stress has an impact on genomic alterations. Of note, FALD and non-Fontan CHS HCCs showed a higher amount of copy number alterations and structural variants, including short deletions and translocations, which were rarely detected in FALD FNH. These structural variants were implicated in frequently altered genes of HCC, suggesting a possible trigger of hepatocarcinogenesis. Transcriptome analysis revealed that individual FALD and non-Fontan CHS HCCs were grouped into the reported HCC subclasses, namely progenitor phenotype, rather than an uncommon HCC subclass. CONCLUSIONS: Genomic mutational profiles of FALD and non-Fontan CHS HCCs are distinct from HCCs with other etiologies. Copy number alterations and transcriptional profiles in FALD HCCs classified these into a poor-prognosis group of HCCs.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yamazoe T, Kakazu E, Matsuda M, et al. Genomic and transcriptomic profiling of hepatocellular carcinoma in patients with Fontan-associated liver disease. Hepatology. 2026. PMID: 41587344. doi:10.1097/HEP.0000000000001693

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。